中国人工智能、机器人、创新药等新产品正在快速开拓海外市场，成为中国外贸的新增长点。2026年上半年，工业机器人出口增长18.6%，销往全球141个国家和地区1；手术机器人出口市场从去年同期的23个扩展到49个1。创新药领域同样表现亮眼，对外授权交易额达约1100亿美元，已达2025年全年总额的八成1。
中国相关企业在细分领域取得显著进展。灵伴科技推出的乐奇AI眼镜是全球最轻的已实现量产的全功能AI眼镜1；擎朗智能的机器人已出口至全球70余个国家和地区1；华沿机器人的双关节模组重复定位精度高达±0.015mm1。在创新药方面，江苏恒瑞医药2026年上半年创新药销售收入88.09亿元，同比增长16.38%，其产品已在50多个国家实现商业化1。官方数据显示，今年上半年批准的11个新靶点、新机制创新药全部由中国药企研发1。
这些成果反映了中国产业升级的持续推进。过去5年，中国全社会研发经费年均增长10%，稳居全球第二1，为制造业向智造转变提供了坚实基础。
Following the success of the "new three products," Chinese enterprises are rapidly expanding their presence in overseas markets with artificial intelligence, robotics, and innovative pharmaceuticals, establishing themselves as fresh symbols of the nation's foreign trade strength.1 In the first half of 2026, industrial robot exports grew by 18.6%, reaching markets across 141 countries and regions, while surgical robots expanded their presence from 23 export destinations in the prior year to 49.1 The sector has attracted significant momentum, with innovative drug licensing agreements reaching approximately 1.1 billion dollars, representing 80 percent of the entire previous year's total.1
These products demonstrate competitive advantages through advanced functionality, scenario-specific adaptation, and sustained innovation.1 Lingban Technology's QiQi AI glasses rank as the world's lightest mass-produced fully functional AI eyewear.1 In the pharmaceutical sector, Jiangsu Hengrui Pharmaceuticals reported innovative drug sales revenue of 8.809 billion yuan in the first half of 2026, reflecting a year-over-year increase of 16.38 percent, with its products achieving commercialization in over 50 countries.1 Qinglang Intelligent's robots have been exported to more than 70 countries and regions globally.1 During the first half of this year, all 11 newly approved innovative drugs with new targets and mechanisms that received official authorization were developed entirely by Chinese pharmaceutical enterprises.1 Over the past five years, China's total social research and development spending has grown at an annual average rate of 10 percent, maintaining the world's second-largest position.1
评论
还没有评论，欢迎留下第一条。